Se connecter Inscription gratuite

Novabay Pharmaceuticals Inc Revenu Y/Y

Quel est le Revenu Y/Y de Novabay Pharmaceuticals Inc?

Le Revenu Y/Y de Novabay Pharmaceuticals Inc est -20.92%

Quelle est la définition de Revenu Y/Y?

La croissance annuelle des revenus des trois dernières années correspond à la croissance moyenne des revenus d’une année sur l’autre au cours des trois dernières années.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Revenu Y/Y des entreprises dans Health Care secteur sur NYSEMKT par rapport à Novabay Pharmaceuticals Inc

Que fait Novabay Pharmaceuticals Inc?

novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across

Entreprises avec revenu y/y similaire à Novabay Pharmaceuticals Inc